BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 29485654)

  • 21. Is it time to target gut dysbiosis and immune dysfunction in the therapy of hepatic encephalopathy?
    Shawcross DL
    Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):539-42. PubMed ID: 25846450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prebiotic effects: metabolic and health benefits.
    Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
    Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammation and hepatic encephalopathy.
    Coltart I; Tranah TH; Shawcross DL
    Arch Biochem Biophys; 2013 Aug; 536(2):189-96. PubMed ID: 23583306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting Clinical Outcomes of Cirrhosis Patients With Hepatic Encephalopathy From the Fecal Microbiome.
    Sung CM; Lin YF; Chen KF; Ke HM; Huang HY; Gong YN; Tsai WS; You JF; Lu MJ; Cheng HT; Lin CY; Kuo CJ; Tsai IJ; Hsieh SY
    Cell Mol Gastroenterol Hepatol; 2019; 8(2):301-318.e2. PubMed ID: 31004827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy.
    Bajaj JS; Betrapally NS; Hylemon PB; Heuman DM; Daita K; White MB; Unser A; Thacker LR; Sanyal AJ; Kang DJ; Sikaroodi M; Gillevet PM
    Hepatology; 2015 Oct; 62(4):1260-71. PubMed ID: 25820757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Intestinal Bacteria and Gut-Brain Axis in Hepatic Encephalopathy.
    Chen Z; Ruan J; Li D; Wang M; Han Z; Qiu W; Wu G
    Front Cell Infect Microbiol; 2020; 10():595759. PubMed ID: 33553004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis.
    Cao Q; Yu CB; Yang SG; Cao HC; Chen P; Deng M; Li LJ
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):9-16. PubMed ID: 29428113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct responsiveness to rifaximin in patients with hepatic encephalopathy depends on functional gut microbial species.
    Yukawa-Muto Y; Kamiya T; Fujii H; Mori H; Toyoda A; Sato I; Konishi Y; Hirayama A; Hara E; Fukuda S; Kawada N; Ohtani N
    Hepatol Commun; 2022 Aug; 6(8):2090-2104. PubMed ID: 35429147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ameliorative Effect of Chitosan Oligosaccharides on Hepatic Encephalopathy by Reshaping Gut Microbiota and Gut-Liver Axis.
    Qi W; Ge Y; Wang X; Li Z; Li X; Wang N; He H; Luo X; Ma W; Chen L; Liu Y; Zhang T
    J Agric Food Chem; 2022 Oct; 70(41):13186-13199. PubMed ID: 36194761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease.
    Dubinkina VB; Tyakht AV; Odintsova VY; Yarygin KS; Kovarsky BA; Pavlenko AV; Ischenko DS; Popenko AS; Alexeev DG; Taraskina AY; Nasyrova RF; Krupitsky EM; Shalikiani NV; Bakulin IG; Shcherbakov PL; Skorodumova LO; Larin AK; Kostryukova ES; Abdulkhakov RA; Abdulkhakov SR; Malanin SY; Ismagilova RK; Grigoryeva TV; Ilina EN; Govorun VM
    Microbiome; 2017 Oct; 5(1):141. PubMed ID: 29041989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut Microbiota and Complications of Liver Disease.
    Acharya C; Bajaj JS
    Gastroenterol Clin North Am; 2017 Mar; 46(1):155-169. PubMed ID: 28164848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the Literature.
    Milosevic I; Vujovic A; Barac A; Djelic M; Korac M; Radovanovic Spurnic A; Gmizic I; Stevanovic O; Djordjevic V; Lekic N; Russo E; Amedei A
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis.
    Ahluwalia V; Betrapally NS; Hylemon PB; White MB; Gillevet PM; Unser AB; Fagan A; Daita K; Heuman DM; Zhou H; Sikaroodi M; Bajaj JS
    Sci Rep; 2016 May; 6():26800. PubMed ID: 27225869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry.
    Sandhu KV; Sherwin E; Schellekens H; Stanton C; Dinan TG; Cryan JF
    Transl Res; 2017 Jan; 179():223-244. PubMed ID: 27832936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity.
    Kaji K; Takaya H; Saikawa S; Furukawa M; Sato S; Kawaratani H; Kitade M; Moriya K; Namisaki T; Akahane T; Mitoro A; Yoshiji H
    World J Gastroenterol; 2017 Dec; 23(47):8355-8366. PubMed ID: 29307995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy.
    Ziada DH; Soliman HH; El Yamany SA; Hamisa MF; Hasan AM
    Arab J Gastroenterol; 2013 Sep; 14(3):116-22. PubMed ID: 24206740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging pathogenic links between microbiota and the gut-lung axis.
    Budden KF; Gellatly SL; Wood DL; Cooper MA; Morrison M; Hugenholtz P; Hansbro PM
    Nat Rev Microbiol; 2017 Jan; 15(1):55-63. PubMed ID: 27694885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synbiotic formulation of probiotic and lactulose combination for hepatic encephalopathy treatment: a realistic hope?
    Sekhar MS; Unnikrishnan MK; Rodrigues GS; Mukhopadhyay C
    Med Hypotheses; 2013 Aug; 81(2):167-8. PubMed ID: 23759357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifibrotic and molecular aspects of rifaximin in alcoholic liver disease: study protocol for a randomized controlled trial.
    Madsen BS; Trebicka J; Thiele M; Israelsen M; Arumugan M; Havelund T; Krag A
    Trials; 2018 Feb; 19(1):143. PubMed ID: 29482588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posttraumatic stress disorder is associated with altered gut microbiota that modulates cognitive performance in veterans with cirrhosis.
    Bajaj JS; Sikaroodi M; Fagan A; Heuman D; Gilles H; Gavis EA; Fuchs M; Gonzalez-Maeso J; Nizam S; Gillevet PM; Wade JB
    Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G661-G669. PubMed ID: 31460790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.